Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

W. Halota · SciRah

Researcher profile · Semantic Scholar

W. Halota

Share profile

W. Halota — researcher profile on SciRah

h-index: 23
Works: 190
Citations: 3,858

Most-cited papers

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B
Ting Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee +10 more
2010Hepatology604 citations Open access
Semantic Scholar
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
M. Cornberg, H. Razavi, A. Alberti, E. Bernasconi +29 more
2011Liver international (Print)446 citations Open access
Semantic Scholar
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
H. Razavi, S. Robbins, S. Zeuzem, F. Negro +111 more
2017The Lancet Gastroenterology and Hepatology240 citations
Semantic Scholar
Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study
R. Flisiak, E. Janczewska, M. Wawrzynowicz-Syczewska, J. Jaroszewicz +25 more
2016Alimentary Pharmacology and Therapeutics109 citations Open access
Semantic Scholar
Prevalence and risk factors of HCV infection in Poland
R. Flisiak, W. Halota, A. Horban, J. Juszczyk +2 more
2011European Journal of Gastroenterology and Hepathology70 citations
Semantic Scholar
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
J. Sperl, G. Horváth, W. Halota, J. A. Ruiz-Tapiador +18 more
2016Journal of Hepatology55 citations
Semantic Scholar
Recommendations for the treatment of hepatitis C in 2017
W. Halota, R. Flisiak, J. Juszczyk, P. Małkowski +3 more
2017Clinical and Experimental Hepatology49 citations Open access
Semantic Scholar
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
Man-Fung Yuen, T. Asselah, Ira M. Jacobson, M. Brunetto +114 more
2023The Lancet Gastroenterology & Hepatology43 citations Open access
Semantic Scholar
The case for simplifying and using absolute targets for viral hepatitis elimination goals
H. Razavi, S. Blach, D. Razavi-Shearer, F. Abaalkhail +199 more
2020Journal of Viral Hepatitis38 citations Open access
Semantic Scholar
Distribution of HCV genotypes in Poland.
A. Panasiuk, R. Flisiak, I. Mozer‐Lisewska, A. Adamek +38 more
2013Przeglad Epidemiologiczny38 citations
Semantic Scholar
Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016
W. Halota, R. Flisiak, A. Boroń‐Kaczmarska, J. Juszczyk +4 more
2016Clinical and Experimental Hepatology30 citations Open access
Semantic Scholar
Treatment of HCV infection in Poland at the beginning of the interferon‐free era—the EpiTer‐2 study
R. Flisiak, D. Zarębska-Michaluk, E. Janczewska, A. Staniaszek +28 more
2018Journal of Viral Hepatitis29 citations Open access
Semantic Scholar
Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial
W. Halota, P. Ferenci, D. Kozielewicz, D. Dybowska +5 more
2015Journal of Viral Hepatitis27 citations
Semantic Scholar
Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020
W. Halota, R. Flisiak, J. Juszczyk, P. Małkowski +3 more
2020Clinical and Experimental Hepatology25 citations Open access
Semantic Scholar
Forecasting the disease burden of chronic hepatitis C virus in Poland
R. Flisiak, W. Halota, K. Tomasiewicz, K. Kostrzewska +2 more
2015European Journal of Gastroenterology and Hepathology25 citations
Semantic Scholar
Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children.
M. Pawłowska, M. Pilarczyk, W. Halota
2010Medical Science Monitor25 citations
Semantic Scholar
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
K. Tomasiewicz, R. Flisiak, W. Halota, J. Jaroszewicz +7 more
2018Clinical and Experimental Hepatology23 citations Open access
Semantic Scholar
Recommendations for the treatment of hepatitis B in 2017
R. Flisiak, W. Halota, J. Jaroszewicz, J. Juszczyk +6 more
2017Clinical and Experimental Hepatology23 citations Open access
Semantic Scholar
Efficacy of HCV treatment in Poland at the turn of the interferon era – the EpiTer study
R. Flisiak, J. Pogorzelska, H. Berak, A. Horban +45 more
2016Clinical and Experimental Hepatology23 citations Open access
Semantic Scholar
Prevalence of HCV genotypes in Poland – the EpiTer study
R. Flisiak, J. Pogorzelska, H. Berak, A. Horban +45 more
2016Clinical and Experimental Hepatology23 citations Open access
Semantic Scholar
What's new in hepatitis C virus infections in children?
M. Pawłowska, K. Domagalski, A. Pniewska, Beata Smok +2 more
2015World Journal of Gastroenterology23 citations Open access
Semantic Scholar
Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4
K. Domagalski, M. Pawłowska, A. Tretyn, W. Halota +3 more
2013Hepatitis Monthly23 citations Open access
Semantic Scholar
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
D. Zarębska-Michaluk, J. Jaroszewicz, A. Parfieniuk-Kowerda, E. Janczewska +22 more
2021Journal of Clinical Medicine20 citations Open access
Semantic Scholar
Changes of patient profile, treatment effectiveness and safety during 4 years access to interferon-free therapy for hepatitis C virus infection.
R. Flisiak, D. Zarębska-Michaluk, J. Jaroszewicz, Beata Lorenc +25 more
2020Polish Archives of Internal Medicine19 citations Open access
Semantic Scholar
Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA
J. Jaroszewicz, M. Pawłowska, K. Simon, D. Zarębska-Michaluk +24 more
2020Expert Review of Anti-Infective Therapy19 citations Open access
Semantic Scholar
Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study
A. Piekarska, E. Jabłonowska, A. Garlicki, M. Sitko +28 more
2020AIDS Care16 citations Open access
Semantic Scholar
Real‐world effectiveness and safety of direct‐acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study
A. Berkan-Kawińska, A. Piekarska, E. Janczewska, Beata Lorenc +27 more
2021Liver international (Print)15 citations Open access
Semantic Scholar
The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C
K. Domagalski, M. Pawłowska, D. Kozielewicz, D. Dybowska +2 more
2015PLoS ONE15 citations Open access
Semantic Scholar
Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study
Paweł Rajewski, D. Zarębska-Michaluk, E. Janczewska, A. Gietka +29 more
2022Journal of Clinical Medicine14 citations Open access
Semantic Scholar
Distribution of HBV genotypes in Poland
M. Świderska, M. Pawłowska, W. Mazur, K. Tomasiewicz +10 more
2015Clinical and Experimental Hepatology14 citations Open access
Semantic Scholar
HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B
M. Pawłowska, W. Halota, E. Smukalska, T. Woźniakowska-Gęsicka +1 more
2011European Journal of Clinical Microbiology and Infectious Diseases14 citations Open access
Semantic Scholar
Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
D. Zarębska-Michaluk, R. Flisiak, J. Jaroszewicz, E. Janczewska +26 more
2018Journal of Interferon and Cytokine Research13 citations Open access
Semantic Scholar
Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus
K. Domagalski, M. Pawłowska, A. Zaleśna, M. Pilarczyk +3 more
2016World Journal of Gastroenterology13 citations Open access
Semantic Scholar
Real‐world experience with Grazoprevir/Elbasvir in the treatment of previously “difficult to treat” patients infected with hepatitis C virus genotype 1 and 4
D. Zarębska-Michaluk, J. Jaroszewicz, I. Buczyńska, K. Simon +25 more
2019Journal of Gastroenterology and Hepatology11 citations Open access
Semantic Scholar
Is an 8‐week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real‐world experience?
D. Zarębska-Michaluk, J. Jaroszewicz, P. Pabjan, T. Łapiński +25 more
2020Journal of Gastroenterology and Hepatology10 citations
Semantic Scholar
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
E. Lathouwers, E. Y. Wong, K. Brown, B. Baugh +159 more
2019AIDS Research and Human Retroviruses10 citations Open access
Semantic Scholar
Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection
M. Pawłowska, M. Pilarczyk, Anna Foksinska, E. Smukalska +1 more
2011Hepatitis Monthly10 citations Open access
Semantic Scholar
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
E. Janczewska, M. F. Kołek, Beata Lorenc, Jakub Klapaczyński +24 more
2021World Journal of Gastroenterology9 citations Open access
Semantic Scholar
Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals
M. Lucejko, Krzysztof Tomasiewicz, A. Olczak, Magdalena Tudrujek-Zdunek +6 more
2019British Journal of Biomedical Science9 citations
Semantic Scholar
Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.
D. Zarębska-Michaluk, A. Piekarska, J. Jaroszewicz, Jakub Klapaczyński +24 more
2019Advances in Medical Sciences9 citations Open access
Semantic Scholar
The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infection
K. Domagalski, M. Pawłowska, A. Zaleśna, M. Tyczyno +3 more
2014European Journal of Clinical Microbiology and Infectious Diseases9 citations
Semantic Scholar
Searching for the optimal population for hepatitis C virus screening in Poland
A. Piekarska, K. Tomasiewicz, W. Halota, J. Jaroszewicz +7 more
2020Clinical and Experimental Hepatology8 citations Open access
Semantic Scholar
Recommendations for treatment of hepatitis C. Polish Group of HCV Experts – 2015
W. Halota, R. Flisiak, A. Boroń‐Kaczmarska, J. Juszczyk +4 more
2015Clinical and Experimental Hepatology8 citations Open access
Semantic Scholar
Recommendations for the treatment of viral hepatitis C in 2018 by Polish Group of Experts for HCV
W. Halota, R. Flisiak, Jacek Juszczyk, P. Małkowski +3 more
2018Zakażenia XXI wieku7 citations
Semantic Scholar
Ulceroglandular tularemia complicated by pneumonia--a case report.
Małgorzata Sobolewska-Pilarczyk, M. Pawłowska, W. Halota
2014Przeglad Epidemiologiczny7 citations
Semantic Scholar
Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz
Małgorzata Tyczyno, W. Halota, Wojciech Nowak, M. Pawłowska
2014Hepatitis Monthly7 citations Open access
Semantic Scholar
Impact of IL-28 B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4
K. Domagalski, A. Tretyn, W. Halota, M. Pilarczyk +3 more
20137 citations
Semantic Scholar
Efficacy of Pegylated Interferon &agr;-2b and Ribavirin in Chronic Hepatitis C Virus (Genotypes 1 and 4) Infection
M. Wiśniewska-Ligier, M. Pawłowska, M. Pilarczyk, W. Halota +1 more
2013Journal of Pediatric Gastroenterology and Nutrition - JPGN7 citations Open access
Semantic Scholar
Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study.
W. Sluzewski, A. Kowala-Piaskowska, J. Wysocki, M. Figlerowicz +9 more
2012Acta Poloniae Pharmaceutica - Drug Research7 citations
Semantic Scholar
Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study
O. Tronina, M. Durlik, Iwona Orłowska, Beata Lorenc +19 more
2021Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Flisiak×33
Invite
R. Flisiak — researcher profile on SciRah
M. Pawłowska×31
Invite
M. Pawłowska — researcher profile on SciRah
K. Tomasiewicz×28
Invite
K. Tomasiewicz — researcher profile on SciRah
K. Simon×24
Invite
K. Simon — researcher profile on SciRah

×22

Invite

A. Piekarska — researcher profile on SciRah

D. Zarębska-Michaluk×18

Invite

D. Zarębska-Michaluk — researcher profile on SciRah

J. Jaroszewicz×16

Invite

J. Jaroszewicz — researcher profile on SciRah

E. Janczewska×15

Invite

E. Janczewska — researcher profile on SciRah

Invite

W. Mazur — researcher profile on SciRah

Invite

H. Berak — researcher profile on SciRah

Invite

O. Tronina — researcher profile on SciRah

Invite

R. Krygier — researcher profile on SciRah